Schedule 13D ownership disclosure

TG THERAPEUTICS INC COM

Security class unavailable · CUSIP: 88322Q108

Event date: 2018-05-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-18-195773
Form type
SC 13D/A
Filer
LFB Biotechnologies S.A.S.U.
CIK
CIK 1377942
Filed
Jun 18, 2018
Reporting period
May 15, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub